Akebia Therapeutics AKBA
NASDAQ AKBA
$0.57 +0.01 (+1.79%)
At close: Oct 23, 2026 · 4:00 PM EDT

Akebia Therapeutics (AKBA) Sale and Maturity of Investments (2014 - 2021)

Updated

Analysis

Akebia Therapeutics (AKBA) Sale and Maturity of Investments (2014 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Akebia Therapeutics 154.89 Mn -514.59 Mn 38.70 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 20.00 Mn
Mar 31, 2021 20.00 Mn
Dec 31, 2020 60.00 Mn
Mar 31, 2020 245,000.00
Dec 31, 2019 22.50 Mn
Sep 30, 2019 26.92 Mn
Jun 30, 2019 56.01 Mn
Mar 31, 2019 112.40 Mn
Dec 31, 2018 63.18 Mn
Sep 30, 2018 62.29 Mn
Jun 30, 2018 69.47 Mn
Mar 31, 2018 61.33 Mn
Dec 31, 2017 52.13 Mn
Sep 30, 2017 43.75 Mn
Jun 30, 2017 29.63 Mn
Mar 31, 2017 24.49 Mn
Dec 31, 2016 37.23 Mn
Sep 30, 2016 60.28 Mn
Jun 30, 2016 49.56 Mn
Mar 31, 2016 15.31 Mn
API Access

Akebia Therapeutics Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=AKBA&period=max&api_key=YOUR_API_KEY